Effects of central hypocretin-1 administration on hemodynamic responses in young-adult and middle-aged rats

Brain Research

Volumn 981, Issue 1-2, 2003, Pages 143-150

  Hirota, Kazuyoshi ^a   Kushikata, Tetsuya ^a   Kudo, Mihoko ^a   Kudo, Tsuyoshi ^a   Smart, Darren ^b   Matsuki, Akitomo ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Catecholamine; Hemodynamics; Hypocretin; Middle age; Rat

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; CATECHOLAMINE; HYPOCRETIN RECEPTOR 1 ANTAGONIST; NORADRENALIN; OREXIN A; PENTOBARBITAL; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; 1 (2 METHYLBENZOXAZOL 6 YL) 3 (1,5)NAPHTHYRIDIN 4 YL UREA; 1-(2-METHYLBENZOXAZOL-6-YL)-3-(1,5)NAPHTHYRIDIN-4-YL UREA; BENZOXAZOLE DERIVATIVE; CARRIER PROTEIN; DRUG DERIVATIVE; HEMOGLOBIN; NEUROPEPTIDE; OREXINS; POTASSIUM CHLORIDE; SIGNAL PEPTIDE; UREA;

ADRENERGIC SYSTEM; AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BRAIN SLICE; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; HEART RATE; HEMODYNAMIC MONITORING; HEMODYNAMICS; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; AGING; ANIMAL; BLOOD; BLOOD GAS ANALYSIS; BLOOD PRESSURE; BRAIN CORTEX; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; PHYSIOLOGY; TIME;

AGING; ANIMALS; BENZOXAZOLES; BLOOD GAS ANALYSIS; BLOOD PRESSURE; CARRIER PROTEINS; CEREBRAL CORTEX; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; HEART RATE; HEMODYNAMIC PROCESSES; HEMOGLOBINS; INJECTIONS, INTRAVENTRICULAR; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NEUROPEPTIDES; NOREPINEPHRINE; POTASSIUM CHLORIDE; RATS; TIME FACTORS; UREA;

EID: 0141463751     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)03002-6     Document Type: Article

References (40)

1. Antunes V.R., Brailoiu G.C., Kwok E.H., Scruggs P., Dun N.J. Orexins/hypocretins excite rat sympathetic preganglionic neurons in vivo and in vitro. Am. J. Physiol. 281:2001;R1801-R1807.
2. Barnet S.R., Morin R.J., Kiely D.K., Ganon M., Azhar G., Knight E.L., Nelson J.C., Lipsitz L.A. Effects of age and gender on autonomic control of blood pressure dynamics. Hypertension. 33:1999;1195-1200.
3. Bingham S., Davey P.T., Babbs A.J., Irving E.A., Sammons M.J., Wyles M., Jeffrey P., Cutler L., Riba I., Johns A., Porter R.A., Upton N., Hunter A.J., Parsons A.A. Orexin-A, an hypothalamic peptide with analgesic properties. Pain. 92:2001;81-90.
4. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 98:1999;437-451.
5. Chen C.T., Hwang L.L., Chang J.K., Dun N.J. Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats. Am. J. Physiol. 278:2000;R692-R697.
6. Date Y., Ueta Y., Yamashita H., Yamaguchi H., Matsukura S., Kanagawa K., Sakurai T., Yanagisawa M., Nakazato M. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. USA. 96:1999;748-753.
7. Evans M.L., Harries M., Patel S., Benham C.D. Orexin A depolarises neurones in the rat locus coeruleus brain slice in vitro. J. Physiol. 515:1999;121P.
8. Folkow B., Svanborg A. Physiology of cardiovascular aging. Physiol. Rev. 73:1993;725-764.
9. Gajjar D., Egan B., Cure J., Rust P., VanTassel P., Patel S.J. Vascular compression of the rostral ventrolateral medulla in sympathetic mediated essential hypertension. Hypertension. 36:2000;78-82.
10. Galarza C.R., Alfie J., Waisman G.D., Mayorga L.M., Camera L.A., del Rio M., Vasvari F., Limansky R., Farias J., Tessler J., Camera M.I. Diastolic pressure underestimates age-related hemodynamic impairment. Hypertension. 30:1997;809-816.
11. Gonzalez M.M., Debilly G., Valatx J.L. Noradrenaline neurotoxin DSP-4 effects on sleep and brain temperature in the rat. Neurosci. Lett. 248:1998;93-96.
12. Guyenet P.G. Neural structures that mediate sympathoexcitation during hypoxia. Respir. Physiol. 121:2000;147-162.
13. Hagan J.J., Leslie R.A., Patel S., Evans M.L., Wattam T.A., Holmes S., Benham C.D., Taylor S.G., Routledge C., Hemmati P., Munton R.P., Ashmeade T.E., Shah A.S., Hatcher J.P., Hatcher P.D., Jones D.N., Smith M.I., Piper D.C., Hunter A.J., Porter R.A., Upton N. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. USA. 96:1999;10911-10916.
14. Hastings J.A., McClure-Sharp J.M., Morris M.J. In vitro studies of endogenous noradrenaline and NPY overflow from the rat hypothalamus during maturation and ageing. Nauyn. Schmiedbergs. Arch. Pharmacol. 357:1998;218-224.
15. Hirota K., Matsunami K., Kudo T., Ishihara H., Matsuki A. Relationship between bispectral index and plasma catecholamines after oral diazepam premedication. Eur. J. Anaesthesiol. 6:1999;516-518.
16. Hirota K., Kushikata T., Kudo M., Kudo T., Lambert D.G., Matsuki A. Orexin A and B evoke noradrenaline release from rat cerebrocortical slices. Br. J. Pharmacol. 134:2001;1461-1466.
17. Ishida Y., Shirokawa T., Miyaisihi O., Komatsu Y., Isobe K. Age-dependent changes in projections from locus coerleus to hippocampus dentate gyrus and frontal cortex. Eur. J. Neurosci. 12:2000;1263-1270.
18. Jones B.E. The role of noradrenergic locus coeruleus neurons and neighboring cholinergic neurons of the pontomesencephalic tegmentum in sleep-wake states. Prog. Brain. Res. 88:1991;533-543.
19. Katoh T., Bito H., Sato S. Influence of age on hypnotic requirement, bispectral index, and 95% spectral edge frequency associated with sedation induced by sevoflurane. Anesthesiology. 92:2000;55-61.
20. Konig S.A., Offner B., Czachurski J., Seller H. Effects of inhibitors of enzymatic and cellular pH-regulating systems on central sympathetic chemosensitivity. Pflugers. Arch. 430:1995;690-696.
21. Kubota T., Anzawa N., Hirota K., Yoshida H., Matsuki A. Effects of ketamine and pentobarbital on norepinephrine release from the median frontal cortex in rats. Can. J. Anaesth. 46:1999;388-392.
22. Lucini D., Mela G.S., Malliani A., Pagani M. Impairment in cardiac autonomic regulation preceding arterial hypertension in humans. Circulation. 106:2002;2673-2679.
23. Matsumura K., Tsuchihashi T., Abe I. Central orexin-A augments sympathoadrenal outflow in conscious rabbits. Hypertension. 37:2001;1382-1387.
24. Merhi M., Helm D., Khalil Z. Age-related changes in sympathetic modulation of sensory nerve activity in rat skin. Inflamm. Res. 47:1998;239-244.
25. Morimoto S., Sasaki S., Itoh H., Nakata T., Takeda K., Nakagawa M., Furuya S., Naruse S., Fukuyama R., Fushiki S. Sympathetic activation and contribution of genetic factors in hypertension with neurovascular compression of the rostral ventrolateral medulla. J. Hypertens. 17:1999;1577-1582.
26. Morita H., Nishida Y., Uemura N., Hosomi H. Effect of pentobarbital anesthesia on renal sympathetic nerve activity in the rabbit. J. Auton. Nerv. Syst. 20:1987;57-64.
27. Nutt D.J., Lalies M.D., Lion L.A., Hudson A.L. Noradrenergic mechanisms in the prefrontal cortex. J. Psychopharmacol. 11:1997;163-168.
28. Osaka T., Matsumura H. Noradrenergic inputs to sleep-related neurons in the preoptic area from the locus coeruleus and the ventrolateral medulla in the rat. Neurosci. Res. 19:1994;39-50.
29. Pears E., Hannaford P.C., Taylor M.W. Gender, age and deprivation differences in the primary care management of hypertension in Scotland: a cross-sectional database study. Fam. Prac. 20:2003;22-31.
30. Peyron C., Tighe D.K., Van Den Pol A.N., De Leces L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18:1998;9996-10015.
31. Rehman H.U., Masson E.A. Neuroendocrinology of aging. Age Aging. 30:2001;279-287.
32. Rodgers R.J., Halford J.C., Nunes de Souza R.L., Canto de Souza A.L., Piper D.C., Arch J.R., Upton N., Porter R.A., Johns A., Blundell J.E. SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur. J. Neurosci. 13:2001;1444-1452.
33. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behaviour. Cell. 92:1998;573-585.
34. Shirasaka T., Nakazato M., Matsukura S., Takasaki M., Kannan H. Sympathetic and cardiovascular actions of orexins in conscious rats. Am. J. Physiol. 277:1999;R1780-R1785.
35. Smart D., Sabido-David C., Brough S.J., Jewitt F., Johns A., Porter R.A., Jerman J.C. SB-334867-A: the first selective orexin-1 receptor antagonist. Br. J. Pharmacol. 132:2001;1179-1182.
36. Soffin E.M., Evans M.L., Gill C.H., Harries M.H., Benham C.D., Davies C.H. SB-334867-A antagonises orexin mediated excitation in the locus coeruleus. Neuropharmacology. 42:2002;127-133.
37. Stanski D.R. Monitoring depth of anesthesia. Miller R.D. Anesthesia. 5th Edition :2000;1087-1116 Churchill Livingstone, New York.
38. Van den Pol A.N., Gao X.B., Obrietan K., Kilduff T.S., Belousov A.B. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J. Neurosci. 18:1998;7962-7971.
39. Wixson S.K., White W.J., Hughes Jr H.C., Lang C.M., Marshall W.K. The effects of pentobarbital, fentanyl-droperidol, ketamine-xylazine and ketamine-diazepam on arterial blood pH, blood gases, mean arterial blood pressure and heart rate in adult male rats. Lab. Anim. Sci. 37:1987;736-742.
40. Zhang J.H., Sampogna S., Morales F.R., Chase M.H. Age-related changes in hypocretin (orexin) immunoreactivity in the rats. Brain. Res. 930:2002;206-211.